(Pulocimab)Biosimilar Reference Antibody-GS40573

货号：GS40573

Pulocimab is a humanized IgG1 monoclonal antibody targeting VEGFR-2 (KDR). It works by binding to and blocking this key receptor for vascular endothelial growth factor (VEGF), thereby inhibiting the signaling pathway that promotes tumor angiogenesis (new blood vessel formation). This action aims to starve tumors of oxygen and nutrients, suppressing their growth and metastasis in various solid cancers.